Venus Concept Announces $17 Million Equity Financing led by Masters Special Situations
Retrieved on:
Wednesday, December 15, 2021
Venus, Company, Securities Act of 1933, Securities Exchange Act of 1934, Hair, Growth, Sale, Industry, Journal of Cosmetic Dermatology, COVID-19, Annual report, NASDAQ, SEC, LLC, Master, Private, MSS, Safety, Scalp, Private placement, ARTAS, Dell Medical School, Dermatology, University, Moses Austin, FUE, GLOBE, Aime, Partnership, Communication, Security (finance), Financial adviser
The financing was led by a new investor - Masters Special Situations, LLC and affiliates thereof (Masters).
Key Points:
- The financing was led by a new investor - Masters Special Situations, LLC and affiliates thereof (Masters).
- Existing investors, EW Healthcare Partners and HealthQuest Capital, and independent director, Keith Sullivan, also participated in the financing.
- This equity financing provides Venus Concept with the requisite capital to advance our strategic growth initiatives, including our efforts to develop the next generation robotic technology platform for medical aesthetic applications, said Domenic Serafino, Chief Executive Officer and Director of Venus Concept Inc.
- Venus Concepts product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Freedom, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD.